Can Aviva plc Help You To Retire Rich?

Dreaming of wealth in retirement? Here’s how Aviva plc (LON: AV) could help you get there.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

avivaOften, the most profitable investments are turnaround stocks. Those companies that are trading on low valuations and that require a significant amount of management input to turn their bottom lines around.

Of course, such stocks inevitably comes with greater risk than steadier, more stable peers. But they also come with greater potential reward, too.

With Aviva (LSE: AV) (NYSE: AV.US) being at least part-way through a major turnaround plan, here’s how it’s not too late to buy in and why it could help you to retire rich.

New Management

It seems a long time ago that Aviva slashed its dividend in response to a number of challenging years that saw profit turn into a loss in 2012. In fact, it was only 18 months ago and in that time the insurer has moved from strength to strength. For example, it is forecast to post earnings per share (EPS) in the current year that are the highest in recent history.

Indeed, Aviva’s turnaround has been successful thus far as a result of decisive action taken by new management. As mentioned, they slashed the dividend and made the company’s prospects, rather than shareholders’ income, their main focus. They aimed to make Aviva more efficient, smaller and, ultimately, far more profitable. They are in the process of achieving this through the sale of non-core businesses that offer a relatively unattractive risk/reward ratio.

Looking Ahead

Evidence of their success can be seen in the forecasts over the next couple of years for Aviva. Not only is the company due to deliver hugely impressive levels of profitability in the current year, EPS is expected to rise by 9% next year. If met, this will allow the company to increase its dividends per share and the market is currently pencilling in growth of 15.8% next year. That puts Aviva on a forward dividend yield of 3.7%, which is attractive given the company’s strong dividend growth prospects.

Market Sentiment

With the new strategy delivering improved numbers, market sentiment has picked up considerably. Shares in Aviva have risen by 31% over the last year alone (30% more than the FTSE 100 has managed), but there could be much more to come.

That’s because Aviva still trades on a relatively attractive valuation. For example, shares in the company trade on a price to earnings (P/E) ratio of just 11.1, which equates to a price to earnings growth (PEG) ratio of 1.2 when next year’s earnings growth potential is taken into account.

This shows that, while the turnaround plan is well underway, there could be further share price growth to come. As a result, Aviva could make a positive contribution to your retirement plans and help you to enjoy a more abundant retirement.

Peter Stephens owns shares of Aviva. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

British pound data
Investing Articles

Starting with nothing? Here’s why now is the perfect time to start building a passive income

Many are worried that 2026 might be a bad time to start investing in stocks and shares. Our Foolish author…

Read more »

ISA coins
Investing Articles

Decided not to bother with a Stocks and Shares ISA? You might be missing these 3 things!

With a fresh annual allowance for contributing to a Stocks and Shares ISA upon us, what might people who don't…

Read more »

GSK scientist holding lab syringe
Investing Articles

Why is everyone buying GSK shares?

GSK shares have been outperforming the FTSE 100 in 2026. Paul Summers takes a closer look and asks whether this…

Read more »

Middle-aged white man pulling an aggrieved face while looking at a screen
Investing Articles

£10,000 invested in easyJet shares at the start of 2026 is now worth…

Anyone buying easyJet shares will have endured a rough ride since January. Paul Summers wonders whether things could get even…

Read more »

Close-up of a woman holding modern polymer ten, twenty and fifty pound notes.
Investing Articles

5 years ago, £5,000 bought 2,645 Barclays shares. But how many would it buy now?

Despite delivering an impressive return since April 2021, Barclays' shares have lagged the FTSE 100's other banks. James Beard considers…

Read more »

Side of boat fuelled by gas to liquids, advertising Shell GTL Fuel
Investing Articles

5 years ago, £5,000 bought 354 Shell shares. But how many would it buy now?

When it comes to Shell’s numbers, most of them are impressive. And it’s no different when looking at the recent…

Read more »

A rear view of a female in a bright yellow coat walking along the historic street known as The Shambles in York, UK which is a popular tourist destination in this Yorkshire city.
Investing Articles

I asked ChatGPT if I should buy Aviva, Diageo or BAE Systems stock and it said…

Aviva, Diageo and BAE Systems shares are popular FTSE 100 picks. But which of the three does ChatGPT like the…

Read more »

Tesla car at super charger station
Investing Articles

SpaceX’s IPO threatens to leave the Tesla share price on the forecourt

As Elon Musk starts fuelling the engines for a SpaceX IPO, could the Tesla share price get left in the…

Read more »